Back to Duquesne Family Office LLC Duquesne Family Office LLC

TEVATEVA
8 quarters

Position history for Duquesne Family Office LLCDuquesne Family Office LLC's holdings in TEVA PHARMACEUTICAL INDS LTD

Yes. Duquesne Family Office holds 624,999 shares of TEVA (Teva Pharmaceutical Industries), worth $21.2M, as of its Q2 2026 13F filing. It reduced the position by 1,752,286 shares (-73.7%) from Q1 2026. Duquesne Family Office has held TEVA since Q3 2024, across 8 quarterly 13F filings. TEVA is 0.4% of Duquesne Family Office's reported 13F portfolio.

Current Value

$21.2M

Current Shares

624,999

Total Value Change

-$4.6M

Total Shares Change

-802,951

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
624,999
-73.7%
$21.2M0.4%$33.88
0
2026-Q1
Decreased
2.4M
-59.5%
$71.6M2.1%$30.12
0
2025-Q4
Decreased
5.9M
-64.6%
$183.4M4.1%$31.21
0
2025-Q3
Increased
16.6M
+3.9%
$335.2M8.3%$20.20
63
2025-Q2
Increased
16M
+7.3%
$267.6M6.6%$16.76
64
2025-Q1
Increased
14.9M
+65.4%
$228.7M7.5%$15.37
88
2024-Q4
Increased
9M
+530.1%
$198.3M5.3%$22.04
96
2024-Q3
New
1.4M
-
$25.7M0.9%$18.02
56

Other major holders of TEVA: BlackRock, Inc., Capital Research Global Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used